16.83
-0.41(-2.38%)
Currency In USD
| Previous Close | 17.24 |
| Open | 16.7 |
| Day High | 17.11 |
| Day Low | 16.62 |
| 52-Week High | 35.25 |
| 52-Week Low | 13.53 |
| Volume | 926,175 |
| Average Volume | 2.38M |
| Market Cap | 1.69B |
| PE | -3.65 |
| EPS | -4.61 |
| Moving Average 50 Days | 19.06 |
| Moving Average 200 Days | 24.17 |
| Change | -0.41 |
If you invested $1000 in Beam Therapeutics Inc. (BEAM) since IPO date, it would be worth $897.6 as of May 24, 2025 at a share price of $16.83. Whereas If you bought $1000 worth of Beam Therapeutics Inc. (BEAM) shares 3 years ago, it would be worth $535.31 as of May 24, 2025 at a share price of $16.83.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Beam Therapeutics to Highlight New Data from BEAM-101 Program in Sickle Cell Disease at European Hematology Association (EHA) 2025 Congress
GlobeNewswire Inc.
May 14, 2025 1:30 PM GMT
Presentation to Include Updated Data from 17 Sickle Cell Disease Patients in the Ongoing BEACON Phase 1/2 Clinical Trial Evaluating Safety and Efficacy of BEAM-101 Beam to Host Investor Webcast on Friday, June 13, 2025, at 4:00 p.m. ET CAMBRIDGE, Mas
Beam Therapeutics to Participate in 2025 RBC Capital Markets Global Healthcare Conference
GlobeNewswire Inc.
May 13, 2025 11:00 AM GMT
CAMBRIDGE, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that management will participate in a fireside chat at th
Beam Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
GlobeNewswire Inc.
May 12, 2025 8:01 PM GMT
CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the United States (U.S.) Food and Drug Administratio